<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367169">
  <stage>Registered</stage>
  <submitdate>26/09/2014</submitdate>
  <approvaldate>7/10/2014</approvaldate>
  <actrnumber>ACTRN12614001076662</actrnumber>
  <trial_identification>
    <studytitle>Moisturisers in the treatment of foot xerosis in adults: Does cost equate to quality? A randomised, double-blinded clinical trial</studytitle>
    <scientifictitle>A randomised controlled trial to compare efficacy between an expensive moisturiser (Eulactol Heel Balm) and inexpensive moisturiser (Sorbolene cream) in the treatment of foot xerosis in  adults</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Xerosis of the foot or feet</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Dermatological conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Moisturiser - Eulactol Heel Balm
Active ingredient: urea. 2g topically applied daily for 4 weeks. Applied by clinician to ensure adherence to treatment.</interventions>
    <comparator>Moisturiser - Walker's Sorbolene 
Active ingredient: paraffin. 2g topically applied daily for 4 weeks. Applied by clinician to ensure adherence to treatment.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>SRRC score, evaluation scaling roughness, redness and cracks.</outcome>
      <timepoint>Baseline &amp; 4 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>VAS score measuring patient - perceived satisfaction of treatment </outcome>
      <timepoint>4 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction with intervention as scored by VAS</outcome>
      <timepoint>4 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Male or female aged &gt;18 yrs

Diagnosis of xerosis indicated by a SRRC score of &gt;2 in dorsal / plantar foot as diagnosed by clinician

Willing and able to provide written consent

Bilateral Xerosis</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Co-existing dermatological disease which may influence xerosis presentation

Co-existing systemic disease which may affect skin physiology 

Medications which affect skin integrity / physiology

Allergies to moisturiser ingredients

Concomitant moisturiser, antifungal or steroid use</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Upon being screened for inc / exc criteria, participants wiil be randomised &amp; assigned to groups with a 3rd party handing out opaque envelopes revealing allocation to  'A' or 'B' groups.</concealment>
    <sequence>Participants will be allocated into intervention groups via simple randomisation conducted using computerised online sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/12/2014</anticipatedstartdate>
    <actualstartdate>1/02/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/04/2015</actualenddate>
    <samplesize>44</samplesize>
    <actualsamplesize>41</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of South Australia</primarysponsorname>
    <primarysponsoraddress>EDS House North Terrace, Adelaide SA 5001</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University Of South Australia</fundingname>
      <fundingaddress>	EDS House North Terrace, Adelaide SA 5001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Trial to test difference in efficacy between an expensive moisturiser (Eulactol Heel Balm) &amp; inexpensive moisturiser (Walker's Sorbolene) in the treatment of foot xerosis over a 4 weeks period. A secondary cost / benefit analysis will also be conducted to help determine 'value for money' of the interventions</summary>
    <trialwebsite />
    <publication>None to date</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>UniSA Human Research Ethics Committee</ethicname>
      <ethicaddress>EDS House North Terrace, Adelaide SA 5001</ethicaddress>
      <ethicapprovaldate>23/09/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Justin Parker</name>
      <address>UniSA
108 North Terrace, Adelaide SA 5001</address>
      <phone>61421336075</phone>
      <fax />
      <email>parjc003@mymail.unisa.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Justin Parker</name>
      <address>UniSA
108 North Terrace, Adelaide SA 5001</address>
      <phone>61421336075</phone>
      <fax />
      <email>parjc003@mymail.unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Justin Parker</name>
      <address>UniSA
108 North Terrace, Adelaide SA 5001</address>
      <phone>61421336075</phone>
      <fax />
      <email>parjc003@mymail.unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>